Philips has received FDA clearance for its AlluraClarity live image guidance system for radiological interventions. It employs Philips’ proprietary ClarityIQ technology, which consists of a multitude of software and hardware improvements that combine high quality imaging with low X-ray dose. According to Philips, radiation dose is decreased up to 73% in neuroradiology compared to older systems.
The flexible digital imaging pipeline can be specifically tailored for every application from cardiology to neurology. AlluraClarity was introduced outside the US in mid-2012. ClarityIQ technology will also be available as an upgrade for the majority of Philips’ existing monoplane and biplane interventional X-ray systems.
Press release: Philips announces FDA clearance for its AlluraClarity interventional X-ray system…
Product page: AlluraClarity…